JP2023513934A5 - - Google Patents

Info

Publication number
JP2023513934A5
JP2023513934A5 JP2022549462A JP2022549462A JP2023513934A5 JP 2023513934 A5 JP2023513934 A5 JP 2023513934A5 JP 2022549462 A JP2022549462 A JP 2022549462A JP 2022549462 A JP2022549462 A JP 2022549462A JP 2023513934 A5 JP2023513934 A5 JP 2023513934A5
Authority
JP
Japan
Prior art keywords
bacteriophage
composition according
seq
bacteriophage composition
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549462A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018623 external-priority patent/WO2021168147A1/en
Publication of JP2023513934A publication Critical patent/JP2023513934A/ja
Publication of JP2023513934A5 publication Critical patent/JP2023513934A5/ja
Pending legal-status Critical Current

Links

JP2022549462A 2020-02-18 2021-02-18 ブドウ球菌感染症を処置するためのバクテリオファージ組成物 Pending JP2023513934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062978006P 2020-02-18 2020-02-18
US62/978,006 2020-02-18
PCT/US2021/018623 WO2021168147A1 (en) 2020-02-18 2021-02-18 Bacteriophage compositions for treating staphylococcus infection

Publications (2)

Publication Number Publication Date
JP2023513934A JP2023513934A (ja) 2023-04-04
JP2023513934A5 true JP2023513934A5 (https=) 2024-02-22

Family

ID=77272316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549462A Pending JP2023513934A (ja) 2020-02-18 2021-02-18 ブドウ球菌感染症を処置するためのバクテリオファージ組成物

Country Status (8)

Country Link
US (4) US20210252083A1 (https=)
EP (1) EP4106782A4 (https=)
JP (1) JP2023513934A (https=)
CN (1) CN115397447A (https=)
AU (1) AU2021224912A1 (https=)
CA (1) CA3171467A1 (https=)
IL (1) IL295408A (https=)
WO (1) WO2021168147A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872519B1 (en) * 1999-04-27 2005-03-29 Mirus Bio Corporation In vitro process for selecting phage resistant to blood inactivation
US11214773B2 (en) * 2015-09-24 2022-01-04 San Diego State University (Sdsu) Foundation Antibacterial and protective bacteriophage formulations and methods for making and using them
CN110719784A (zh) * 2017-02-13 2020-01-21 阿玛塔制药公司 治疗性噬菌体组合物
EP3372085A1 (en) * 2017-03-08 2018-09-12 Pherecydes Pharma Phage therapy
CN112218659A (zh) * 2018-01-02 2021-01-12 阿玛塔制药股份有限公司 用于治疗葡萄球菌感染的治疗性噬菌体组合物

Similar Documents

Publication Publication Date Title
Łusiak-Szelachowska et al. Bacteriophages and lysins in biofilm control
AU2019222918B2 (en) Antimicrobial peptides and methods of use thereof
IL275795B1 (en) Medical bacteriophage preparations for the treatment of staphylococcus infection
Stevens et al. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature
US20250170195A1 (en) Bacteriophage compositions for treating pseudomonas infections
JP2021527699A5 (https=)
JP2017526627A5 (https=)
JP2022062116A (ja) 療法バクテリオファージ組成物
JP2023523319A5 (https=)
CN111171159A (zh) 抗浮游菌和胞内菌感染的抗菌肽tat-kr-12及其制备方法与应用
JP2023513934A5 (https=)
US20240189373A1 (en) Bacteriophage compositions for treating staphylococcus infection
JP2022525914A (ja) 感染性心内膜炎を治療する方法
JPWO2019176729A1 (ja) 新規バクテリオファージおよび細菌性眼内炎治療剤
AU2019205241C1 (en) Bacteriophage compositions for treating Pseudomonas infections
Godány et al. Phage therapy: Alternative approach to antibiotics
HK40040296A (en) Therapeutics bacteriophage compositions for treating staphylococcus infection
JP2024530170A5 (https=)